Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) and RenovoRx (NASDAQ:RNXT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Earnings & Valuation This table compares Verrica Pharmaceuticals […]
RenovoRx CEO Issues Update Letter to Shareholders marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Data shows that the Trans-Arterial Micro-Perfusion platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy
TAMP offers.
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Shaun R. Bagai, Chief.
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that, in light of its recent.